DE69832270D1 - Isoxazolderivate - Google Patents

Isoxazolderivate

Info

Publication number
DE69832270D1
DE69832270D1 DE69832270T DE69832270T DE69832270D1 DE 69832270 D1 DE69832270 D1 DE 69832270D1 DE 69832270 T DE69832270 T DE 69832270T DE 69832270 T DE69832270 T DE 69832270T DE 69832270 D1 DE69832270 D1 DE 69832270D1
Authority
DE
Germany
Prior art keywords
group
formula
represented
solid line
single bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69832270T
Other languages
English (en)
Other versions
DE69832270T2 (de
Inventor
Masashi Nakatsuka
Yoshihide Ueno
Shin-Ichiro Okada
Fumio Nishikaku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of DE69832270D1 publication Critical patent/DE69832270D1/de
Application granted granted Critical
Publication of DE69832270T2 publication Critical patent/DE69832270T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69832270T 1997-04-21 1998-04-17 Isoxazolderivate Expired - Lifetime DE69832270T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP11887197 1997-04-21
JP11887197 1997-04-21
JP36715497 1997-12-24
JP36715497 1997-12-24
PCT/JP1998/001770 WO1998047880A1 (en) 1997-04-21 1998-04-17 Isoxazole derivatives

Publications (2)

Publication Number Publication Date
DE69832270D1 true DE69832270D1 (de) 2005-12-15
DE69832270T2 DE69832270T2 (de) 2006-07-13

Family

ID=26456721

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69832270T Expired - Lifetime DE69832270T2 (de) 1997-04-21 1998-04-17 Isoxazolderivate

Country Status (14)

Country Link
EP (1) EP0979226B1 (de)
KR (1) KR100512087B1 (de)
CN (1) CN1138764C (de)
AT (1) ATE309228T1 (de)
AU (1) AU733091B2 (de)
CA (1) CA2235298C (de)
DE (1) DE69832270T2 (de)
DK (1) DK0979226T3 (de)
ES (1) ES2248894T3 (de)
ID (1) ID22897A (de)
NZ (1) NZ330244A (de)
RU (1) RU2196770C2 (de)
TW (1) TW442476B (de)
WO (1) WO1998047880A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005774A1 (fr) * 1999-07-15 2001-01-25 Sumitomo Pharmaceuticals Co., Ltd. Composes de cycles heteroaromatiques
WO2001047895A1 (fr) * 1999-12-28 2001-07-05 Sumitomo Pharmaceuticals Company, Limited Nouveaux composes comprenant des cycles heteroaromatiques a cinq chainons
DE60222643T2 (de) * 2001-03-27 2008-07-17 Dainippon Sumitomo Pharma Co., Ltd. Kristallines isoxazol-derivat und medizinisches präparat daraus
WO2003068239A1 (fr) * 2002-02-12 2003-08-21 Sumitomo Pharmaceuticals Co., Ltd. Nouveaux medicaments d'usage externe
ITMI20040019A1 (it) * 2004-01-12 2004-04-12 Univ Bari Derivati isossazolici e loro impiego come inibitori della ciclossigenasi
DE102004008141A1 (de) * 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
EP1815867A4 (de) * 2004-11-02 2010-06-09 Dainippon Sumitomo Pharma Co Kombinationspräparat zur behandlung von autoimmunkrankheit
US7989450B2 (en) 2008-01-11 2011-08-02 Universita' Degli Studi Di Bari Functionalized diarylisoxazoles inhibitors of ciclooxygenase
MY162397A (en) * 2011-01-28 2017-06-15 4Sc Discovery Gmbh Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
DE102014201651A1 (de) * 2014-01-30 2015-07-30 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Isoxazolderivate zur Verwendung bei der Behandlung und/oder Prophylaxe von Herzerkrankungen
CN111269149B (zh) * 2020-04-08 2022-04-15 南京优氟医药科技有限公司 一种5-(3,3-二甲基胍基)-2-氧代戊酸的生产工艺
CN114478350B (zh) * 2022-01-25 2023-08-11 苏州大学 一种c3-烷基化吲哚的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068418A1 (en) * 1969-10-27 1971-08-27 Innothera Lab Sa 2-substd-5-amino isoxazole derivs
US3720685A (en) * 1970-07-15 1973-03-13 Squibb & Sons Inc 3-amino-5-benzyl-1,2,4-oxadiazoles
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
DE2341507A1 (de) * 1973-08-16 1975-02-27 Thomae Gmbh Dr K Neue biphenylderivate und verfahren zur herstellung
JPS54144347A (en) * 1978-05-02 1979-11-10 Nikken Kagaku Kk 3-(2-fluoro-4-biphenylyl)-2-butanone
HU180567B (en) * 1980-03-19 1983-03-28 Egyt Gyogyszervegyeszeti Gyar Method for producing derivatives of isooxazole
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な１，２，４−オキサジアゾ−ル誘導体
US4680300A (en) * 1985-01-10 1987-07-14 Syntex (U.S.A.) Inc. Anti-inflammatory guanidines
US4914112A (en) * 1986-06-03 1990-04-03 Sumitomo Pharmaceuticals Company, Limited Aminoazole derivatives and their production and use
JP2719742B2 (ja) * 1991-04-30 1998-02-25 株式会社大塚製薬工場 フェニルチアゾール誘導体

Also Published As

Publication number Publication date
KR20010006501A (ko) 2001-01-26
CN1138764C (zh) 2004-02-18
CA2235298C (en) 2008-05-13
DK0979226T3 (da) 2006-03-06
TW442476B (en) 2001-06-23
CA2235298A1 (en) 1998-10-21
EP0979226B1 (de) 2005-11-09
KR100512087B1 (ko) 2005-09-05
ATE309228T1 (de) 2005-11-15
AU6193498A (en) 1998-10-22
CN1252794A (zh) 2000-05-10
RU2196770C2 (ru) 2003-01-20
EP0979226A1 (de) 2000-02-16
AU733091B2 (en) 2001-05-03
WO1998047880A1 (en) 1998-10-29
ID22897A (id) 1999-12-16
DE69832270T2 (de) 2006-07-13
NZ330244A (en) 2000-01-28
ES2248894T3 (es) 2006-03-16

Similar Documents

Publication Publication Date Title
DK0889876T3 (da) Meta-substituerede phenylensulfonamidderivater
DE69832270D1 (de) Isoxazolderivate
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
EA199800141A1 (ru) Гетероциклические соединения
CA2318349A1 (en) Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
DE69328856T2 (de) Hypoglykämische Dihydrochalconderivate
EP1541558A4 (de) Heterocyclische verbindung mit hiv-integrase-hemmender wirkung
AU6696390A (en) New tricyclic compounds
EP1302458A4 (de) Esterderivate
AU6583796A (en) Sulfonamide derivatives
DE69809063T2 (de) Aryloxyanilin-derivate
ATE289810T1 (de) Ecteinascidinderivate
EP1500652A4 (de) Chinazolinderivat und arzneimittel
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
KR920004392A (ko) 플루오로에틸캄프토테신 유도체
EP0335979A4 (en) Thienopyrimidine derivatives
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
ATE238300T1 (de) (3,4-dihydro-2h-benzo(1,4)oxazinyl-methyl)-3-(1 - indol-3-yl)-alkylamine
EP0302633A3 (de) Beta-Lactamverbindungen, Verfahren zu ihrer Herstellung, Zwischenprodukte für ihre Synthese und diese enthaltende pharmazeutische Präparate für bakterielle Infektionskrankheitentherapie
AU1424795A (en) Indole derivative
DK0386778T3 (da) Biphenylderivater
CA2245896A1 (en) A therapeutic agent for renal disease
PL353863A1 (en) Bis(1-aziridino-1-hydroxyiminomethyl)-derivatives, method for the production thereof and use thereof as anti-tumoral agents
WO2001074817A1 (fr) Derives d'hydrazide
MX9802679A (es) Derivados de ditiolan, su preparacion y su efecto terapeutico.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DAINIPPON SUMITOMO PHARMA CO., LTD., OSAKA, JP

8364 No opposition during term of opposition